Blood pressure medicine recall today

On 3 November 2026, the U.S. Food and Drug Administration (FDA) issued a formal notification regarding a voluntary nationwide recall of specific lots of Losartan Potassium tablets, a widely prescribed medication used to treat high blood pressure. The recall was initiated by the manufacturer following internal testing that identified trace amounts of a nitrosamine impurity, specifically N-nitroso-N-methyl-4-aminobutyric acid (NMBA), which exceeds the established acceptable daily intake levels. While the company stated that there have been no reports of adverse health events linked to the affected batches to date, the recall is being conducted as a precautionary measure to ensure patient safety. Patients currently taking Losartan are advised to check their prescription bottles against the lot numbers listed on the FDA website. Consumers are strongly encouraged not to discontinue their medication abruptly, as doing so could pose immediate health risks, but rather to contact their healthcare provider or pharmacist immediately to arrange for a replacement prescription. This action reflects ongoing regulatory efforts to monitor pharmaceutical supply chains for potential chemical contaminants.